2022 340B Health Annual Survey: Vital 340B-Supported Patient Services Threatened as Manufacturer Restrictions Cut Into Savings
Link
Description
Summarizes the results of an November - December 2022 survey of 633 hospitals, including small and rural hospitals, that participate in the 340B drug pricing program. Describes how these hospitals utilize their savings from the 340B program to benefit patients. Discusses the importance of the program to Critical Access Hospitals, Disproportionate Share Hospitals, and other safety-net facilities. Outlines the effects of manufacturer restrictions on community and specialty pharmacies.
Date
2022
Type
Document
Organization
340B Health
Tagged as
Access · Hospitals · Pharmacy and prescription drugs · Statistics and data